Zoetis Receives USDA License for Cytopoint Plus™: The First and Only Long-Acting Monoclonal Antibody Providing 75 Days of Allergic Itch Relief in Dogs with Allergic Dermatitis
硕腾硕腾(US:ZTS) Businesswire·2026-11-11 20:30

文章核心观点 - Cytopoint Plus是首个也是唯一一个获得美国农业部许可的新一代单克隆抗体，单次注射可提供75天的过敏性瘙痒缓解 [1] 产品特点 - Cytopoint Plus为新一代mAb产品 [1] - 单次注射即可提供75天的过敏性瘙痒缓解 [1] - 该产品是首个且唯一获得USDA许可的此类新一代mAb [1] 公司与行业 - 该产品隶属于ZTS动物健康业务板块 [1] - 产品发布地点为美国新泽西州帕西帕尼 [1]

Zoetis Receives USDA License for Cytopoint Plus™: The First and Only Long-Acting Monoclonal Antibody Providing 75 Days of Allergic Itch Relief in Dogs with Allergic Dermatitis - Reportify